ArticleBuilding simulation2018
Air infiltration induced inter-unit dispersion and infectious risk assessment in a high-rise residential building.
Article in Building simulation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 19 citations in OpenAlex.
- Airborne transmission of biological agents within the indoor built environment: a multidisciplinary review.Air quality, atmosphere, & health · 2023Review
- Ventilation in worker dormitories and its impact on the spread of respiratory droplets.Sustainable cities and society · 2021Article
- Investigation of potential aerosol transmission and infectivity of SARS-CoV-2 through central ventilation systems.Building and environment · 2021Article
- The role of computational fluid dynamics tools on investigation of pathogen transmission: Prevention and control.The Science of the total environment · 2020Review
- Ventilation and laboratory confirmed acute respiratory infection (ARI) rates in college residence halls in College Park, Maryland.Environment international · 2020Article
- The influence of envelope features on interunit dispersion around a naturally ventilated multi-story building.Building simulation · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 3 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Identifying possible airborne transmission routes and assessing the associated infectious risks are essential for implementing effective control measures. This study focuses on the infiltration-induced inter-unit pollutant dispersion in a high-rise residential (HRR) building. The outdoor wind pressure distribution on the building facades was obtained from the wind tunnel experiments. And the inter-household infiltration and tracer gas transmission were simulated using multi-zone model. The risk levels along building height and under different wind directions were examined, and influence of component leakage area was analysed. It is found that, the cross-infection risk can be over 20% because of the low air infiltration rate below 0.7 ACH, which is significantly higher than the risk of 9% obtained in our previous on-site measurement with air change rate over 3 ACH. As the air infiltration rate increases along building height, cross-infection risk is generally higher on the lower floors. The effect of wind direction on inter-unit dispersion level is significant, and the presence of a contaminant source in the windward side results in the highest cross-infection risks in other adjacent units on the same floor. Properly improving internal components tightness and increasing air change via external components are beneficial to the control of internal inter-unit transmission induced by infiltration. However, this approach may increase the cross-infection via the external transmission, and effective control measures should be further explored considering multiple transmission routes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.